Aethlon Medical Inc. said it appointed Timothy Rodell as the company's interim CEO, effective Dec. 10.

Rodell succeeds James Joyce, who will serve as a consultant to the company during the transition.

Previously, Rodell served as president, CEO and board member of GlobeImmune Inc.

San Diego-based Aethlon Medical is a medical device company that focuses on creating devices that address unmet medical needs in health and biodefense worldwide.